Biotechnology company StemCells Inc. said Thursday it has agreed to a stay in its patent-dispute lawsuit against Neuralstem Inc. while the U.S. Patent and Trademark Office re-examines the patents in question.

StemCells’ lawsuit alleges that stem-cell based products and other services being developed by Neuralstem infringe on four of its patents.